Skip to content
E1 · Randomised trialTrialPEM not requiredPeer-reviewed
Standard · 3 min

Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up.

Fjorback, Lone Overby, Arendt, Mikkel, Ornbøl, Eva et al.

Journal of psychosomatic research2013DOIPubMed

Design
Randomised trial
Participants
Not reported
PEM required
No
Case definition
Not stated in the abstract

Quick Summary

This study tested whether mindfulness therapy (a technique combining meditation and stress-reduction strategies) could help people with conditions like ME/CFS, fibromyalgia, and IBS. Researchers compared mindfulness therapy to enhanced standard medical care in 119 patients over 15 months. While both groups improved similarly overall, people in the mindfulness group improved faster and their gains lasted longer, suggesting mindfulness may be a helpful option worth considering.

Why It Matters

This study directly addresses ME/CFS as part of bodily distress syndrome and evaluates a non-pharmaceutical intervention that could complement standard care. Understanding whether mindfulness-based approaches can improve physical quality of life and symptom burden is valuable for patients seeking additional treatment options alongside medical management.

Observed Findings

What the study reports it measured.

  • Both mindfulness therapy and enhanced treatment as usual groups achieved clinically significant improvements in physical health scores (approximately 0.5 standard deviation change) by 15-month follow-up.
  • The mindfulness therapy group showed improvement emerging toward the end of treatment that persisted at 15-month follow-up, whereas the control group did not show significant change until the 15-month assessment.
  • Approximately 29% of patients in both groups showed clinically important change exceeding 1 standard deviation.
  • Significant between-group differences favoring mindfulness therapy were observed at the point of treatment cessation.

Inferred Conclusions

What the authors interpret from those results.

  • Mindfulness therapy is feasible and acceptable for patients with bodily distress syndrome including ME/CFS, fibromyalgia, and IBS.
  • Mindfulness therapy produces clinically important improvements comparable to enhanced standard medical care.
  • The more rapid improvement trajectory in the mindfulness group suggests potential advantages in symptom relief timing, even if overall 15-month outcomes are similar.

Remaining Questions

  • Does mindfulness therapy provide sustained benefit beyond 15 months, or do gains plateau or diminish with time?
  • What patient characteristics predict who will benefit most from mindfulness-based approaches versus standard care alone?
  • Why does the mindfulness group show earlier improvement while both groups converge by 15 months—are different mechanisms driving change in each group?
  • How does mindfulness therapy specifically address post-exertional malaise and other ME/CFS-specific symptoms?

What This Study Does Not Prove

This study does not prove that mindfulness therapy is superior to standard care—the primary statistical analysis showed no significant difference between groups. The study also does not establish whether mindfulness benefits persist long-term beyond 15 months, nor does it identify which ME/CFS patients might benefit most from this intervention. Longer follow-up and larger trials would be needed to confirm durability and applicability.

Explore further

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Cite this study

The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.

Primary citation

Fjorback, Lone Overby, Arendt, Mikkel, Ornbøl, Eva, Walach, Harald, Rehfeld, Emma, Schröder, Andreas, et al. (2013). Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up.. Journal of psychosomatic research. https://doi.org/10.1016/j.jpsychores.2012.09.006

BibTeX

@article{mecfsatlas-fjorback-2013-mindfulness-therapy,
  author  = {Fjorback, Lone Overby and Arendt, Mikkel and Ornbøl, Eva and Walach, Harald and Rehfeld, Emma and Schröder, Andreas and Fink, Per},
  title   = {Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up.},
  journal = {Journal of psychosomatic research},
  year    = {2013},
  doi     = {10.1016/j.jpsychores.2012.09.006},
  note    = {PubMed: 23272986},
  url     = {https://www.mecfsatlas.com/evidence/fjorback-2013-mindfulness-therapy},
}

Atlas snapshot reference

ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-14. https://www.mecfsatlas.com/evidence/fjorback-2013-mindfulness-therapy

Contribute

Private, reviewed by a human. Not a public comment thread.